Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Income: 2020-2025

Historic Net Income for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.

  • IDEAYA Biosciences' Net Income rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Net Income of $108.5 million as of Q3 2025, which was up 175.24% from -$144.1 million recorded in Q4 2024.
  • In the past 5 years, IDEAYA Biosciences' Net Income registered a high of $108.5 million during Q3 2025, and its lowest value of -$144.1 million during Q4 2024.
  • For the 3-year period, IDEAYA Biosciences' Net Income averaged around -$39.2 million, with its median value being -$41.9 million (2023).
  • Per our database at Business Quant, IDEAYA Biosciences' Net Income tumbled by 5,179.70% in 2023 and then surged by 262.13% in 2025.
  • IDEAYA Biosciences' Net Income (Quarterly) stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then crashed by 58.52% to -$41.9 million in 2023, then tumbled by 243.87% to -$144.1 million in 2024, then skyrocketed by 262.13% to $108.5 million in 2025.
  • Its Net Income stands at $108.5 million for Q3 2025, versus -$144.1 million for Q4 2024 and -$66.9 million for Q3 2024.